ZANDA, MATTEO
ZANDA, MATTEO
SAC - soppressa (attivo dal 18/11/1923 al 31/12/2021)
Recent Advances in the Synthesis and Medicinal Chemistry of SF5 and SF4Cl Compounds
2022 Sani, Monica; Zanda, Matteo
Synthesis, Radiosynthesis, and in vitro Studies on Novel Hypoxia PET Tracers Incorporating [18F]FDR
2021 Musolino M.; Fleming I.N.; Schweiger L.F.; O'Hagan D.; Dall'Angelo S.; Zanda M.
4,4,16-Trifluoropalmitate: Design, Synthesis, Tritiation, Radiofluorination and Preclinical PET Imaging Studies on Myocardial Fatty Acid Oxidation
2020 Colombano A.; Dall'Angelo S.; Kingston L.; Gronberg G.; Correia C.; Passannante R.; Baz Z.; Morcillo M.A.; Elmore C.S.; Llop J.; Zanda M.
[F-18]ZCDD083: A PFKFB3-Targeted PET Tracer for Atherosclerotic Plaque Imaging
2020 De Dominicis, Carlo; Perrotta, Paola; Dall'Angelo, Sergio; Wyffels, Leonie; Staelens, Steven; De Meyer, G R Y; Zanda, Matteo
Design, Synthesis, Conjugation, and Reactivity of Novel trans,trans-1,5-Cyclooctadiene-Derived Bioorthogonal Linkers
2020 Longo, B; Zanato, C; Piras, M; Dall'Angelo, S; Windhorst, Ad; Vugts, Dj; Baldassarre, M; Zanda, M
Design, Synthesis, Radiosynthesis and Biological Evaluation of Fenretinide Analogues as Anticancer and Metabolic Syndrome-Preventive Agents
2020 Patruno, I; Thompson, D; Dall'Angelo, S; Windhorst, Ad; Vugts, Dj; Poot, Aj; Mody, N; Zanda, M
Highly Strained Unsaturated Carbocycles
2020 Zanda M.; Bucci R.; Sloan N.L.; Topping L.
The Trifluoromethyl Group as a Bioisosteric Replacement of the Aliphatic Nitro Group in CB1 Receptor Positive Allosteric Modulators
2019 Tseng C.C.; Baillie G.; Donvito G.; Mustafa M.A.; Juola S.E.; Zanato C.; Massarenti C.; Dall'Angelo S.; Harrison W.T.A.; Lichtman A.H.; Ross R.A.; Zanda M.; Greig I.R.
Preclinical Evaluation of [18F]LCATD as a PET Tracer to Study Drug-Drug Interactions Caused by Inhibition of Hepatic Transporters
2018 Testa, Andrea; Dall'Angelo, Sergio; Mingarelli, Marco; Augello, Andrea; Schweiger, Lutz; Welch, Andrew; S Elmore, Charles; Dawson, Dana; Sharma, Pradeep; Zanda, Matteo
Design, synthesis, in vitro characterization and preliminary imaging studies of fluorinated bile acid derivatives as PET tracefrs to study hapatic transporters
2017 Testa, A; Dall'Angelo, S; Mingarelli, M; Augello, A; Schweiger, L; Welch, A; Elmore, Cs; Sharma, P; Zanda, M
Development of Fluorinated Analogues of Perhexiline with Improved Pharmacokinetic Properties and Retained Efficacy
2017 Tseng, Cc; Noordali, H; Sani, M; Madhani, M; Grant, Dm; Frenneaux, Mp; Zanda, M; Greig, Ir
High-Affinity "Click" RGD Peptidomimetics as Radiolabeled Probes for Imaging ?v ?3 Integrin
2017 Piras, M; Testa, A; Fleming, In; Dall'Angelo, S; Andriu, A; Menta, S; Mori, M; Brown, Gd; Forster, D; Williams, Kj; Zanda, M
KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulation.
2017 Lazzari, P; Spiga, M; Sani, M; Zanda, M; Fleming, In
Synthesis and Superpotent Anticancer Activity of Tubulysins Carrying Non-hydrolysable N-Substituents on Tubuvaline
2017 Sani, M; Lazzari, P; Folini, M; Spiga, M; Zuco, V; De Cesare, M; Manca, I; Dall'Angelo, S; Frigerio, M; Usai, I; Testa, A; Zaffaroni, N; Zanda, M
Synthesis, radio-synthesis and in vitro evaluation of terminally fluorinated derivatives of HU-210 and HU-211 as novel candidate PET tracers
2017 Zanato, C; Pelagalli, A; Marwick, Kfm; Piras, M; Dall'Angelo, S; Spinaci, A; Pertwee, Rg; Wyllie, Dja; Hardingham, Ge; Zanda, M
A critical review of both the synthesis approach and the receptor profile of the 8-chloro-1-(2',4'-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-Tetrahydrobenzo[6,7]cyclohepta[1,2-c ]pyrazole-3-carboxamide and analogue derivatives
2016 Lazzari P.; Distinto R.; Manca I.; Baillie G.; Murineddu G.; Pira M.; Falzoi M.; Sani M.; Morales P.; Ross R.; Zanda M.; Jagerovic N.; Pinna G.A.
Asymmetric Synthesis and Absolute Configuration of (+)- and (-)-Perhexiline
2016 Tseng, Chih Chung; Greig, Iain R.; Harrison, William T A; Zanda, Matteo; Zanda, Matteo
NGR Tumor-Homing Peptides: Structural Requirements for Effective APN (CD13) Targeting
2016 Graziadio, A; Zanda, M; Frau, S; Fleming, In; Musolino, M; Dallangelo, S; Baldassarre, M; Piras, M
4-Cyano-5-(2-thiophenyl)-pyrazoles are high affinity CB1 receptor ligands
2015 Altomonte, Stefano; Baillie, Gemma L.; Ross, Ruth A.; Zanda, Matteo
An Efficient Route to N-Monosubstituted Guanidino-Lactams
2015 Tommasi S.; Zanato C.; Carabeo R.; Mangoni A.A.; Dall'Angelo S.; Zanda M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Recent Advances in the Synthesis and Medicinal Chemistry of SF5 and SF4Cl Compounds | 1-gen-2022 | Sani, Monica; Zanda, Matteo | |
| Synthesis, Radiosynthesis, and in vitro Studies on Novel Hypoxia PET Tracers Incorporating [18F]FDR | 1-gen-2021 | Musolino M.; Fleming I.N.; Schweiger L.F.; O'Hagan D.; Dall'Angelo S.; Zanda M. | |
| 4,4,16-Trifluoropalmitate: Design, Synthesis, Tritiation, Radiofluorination and Preclinical PET Imaging Studies on Myocardial Fatty Acid Oxidation | 1-gen-2020 | Colombano A.; Dall'Angelo S.; Kingston L.; Gronberg G.; Correia C.; Passannante R.; Baz Z.; Morcillo M.A.; Elmore C.S.; Llop J.; Zanda M. | |
| [F-18]ZCDD083: A PFKFB3-Targeted PET Tracer for Atherosclerotic Plaque Imaging | 1-gen-2020 | De Dominicis, Carlo; Perrotta, Paola; Dall'Angelo, Sergio; Wyffels, Leonie; Staelens, Steven; De Meyer, G R Y; Zanda, Matteo | |
| Design, Synthesis, Conjugation, and Reactivity of Novel trans,trans-1,5-Cyclooctadiene-Derived Bioorthogonal Linkers | 1-gen-2020 | Longo, B; Zanato, C; Piras, M; Dall'Angelo, S; Windhorst, Ad; Vugts, Dj; Baldassarre, M; Zanda, M | |
| Design, Synthesis, Radiosynthesis and Biological Evaluation of Fenretinide Analogues as Anticancer and Metabolic Syndrome-Preventive Agents | 1-gen-2020 | Patruno, I; Thompson, D; Dall'Angelo, S; Windhorst, Ad; Vugts, Dj; Poot, Aj; Mody, N; Zanda, M | |
| Highly Strained Unsaturated Carbocycles | 1-gen-2020 | Zanda M.; Bucci R.; Sloan N.L.; Topping L. | |
| The Trifluoromethyl Group as a Bioisosteric Replacement of the Aliphatic Nitro Group in CB1 Receptor Positive Allosteric Modulators | 1-gen-2019 | Tseng C.C.; Baillie G.; Donvito G.; Mustafa M.A.; Juola S.E.; Zanato C.; Massarenti C.; Dall'Angelo S.; Harrison W.T.A.; Lichtman A.H.; Ross R.A.; Zanda M.; Greig I.R. | |
| Preclinical Evaluation of [18F]LCATD as a PET Tracer to Study Drug-Drug Interactions Caused by Inhibition of Hepatic Transporters | 1-gen-2018 | Testa, Andrea; Dall'Angelo, Sergio; Mingarelli, Marco; Augello, Andrea; Schweiger, Lutz; Welch, Andrew; S Elmore, Charles; Dawson, Dana; Sharma, Pradeep; Zanda, Matteo | |
| Design, synthesis, in vitro characterization and preliminary imaging studies of fluorinated bile acid derivatives as PET tracefrs to study hapatic transporters | 1-gen-2017 | Testa, A; Dall'Angelo, S; Mingarelli, M; Augello, A; Schweiger, L; Welch, A; Elmore, Cs; Sharma, P; Zanda, M | |
| Development of Fluorinated Analogues of Perhexiline with Improved Pharmacokinetic Properties and Retained Efficacy | 1-gen-2017 | Tseng, Cc; Noordali, H; Sani, M; Madhani, M; Grant, Dm; Frenneaux, Mp; Zanda, M; Greig, Ir | |
| High-Affinity "Click" RGD Peptidomimetics as Radiolabeled Probes for Imaging ?v ?3 Integrin | 1-gen-2017 | Piras, M; Testa, A; Fleming, In; Dall'Angelo, S; Andriu, A; Menta, S; Mori, M; Brown, Gd; Forster, D; Williams, Kj; Zanda, M | |
| KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulation. | 1-gen-2017 | Lazzari, P; Spiga, M; Sani, M; Zanda, M; Fleming, In | |
| Synthesis and Superpotent Anticancer Activity of Tubulysins Carrying Non-hydrolysable N-Substituents on Tubuvaline | 1-gen-2017 | Sani, M; Lazzari, P; Folini, M; Spiga, M; Zuco, V; De Cesare, M; Manca, I; Dall'Angelo, S; Frigerio, M; Usai, I; Testa, A; Zaffaroni, N; Zanda, M | |
| Synthesis, radio-synthesis and in vitro evaluation of terminally fluorinated derivatives of HU-210 and HU-211 as novel candidate PET tracers | 1-gen-2017 | Zanato, C; Pelagalli, A; Marwick, Kfm; Piras, M; Dall'Angelo, S; Spinaci, A; Pertwee, Rg; Wyllie, Dja; Hardingham, Ge; Zanda, M | |
| A critical review of both the synthesis approach and the receptor profile of the 8-chloro-1-(2',4'-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-Tetrahydrobenzo[6,7]cyclohepta[1,2-c ]pyrazole-3-carboxamide and analogue derivatives | 1-gen-2016 | Lazzari P.; Distinto R.; Manca I.; Baillie G.; Murineddu G.; Pira M.; Falzoi M.; Sani M.; Morales P.; Ross R.; Zanda M.; Jagerovic N.; Pinna G.A. | |
| Asymmetric Synthesis and Absolute Configuration of (+)- and (-)-Perhexiline | 1-gen-2016 | Tseng, Chih Chung; Greig, Iain R.; Harrison, William T A; Zanda, Matteo; Zanda, Matteo | |
| NGR Tumor-Homing Peptides: Structural Requirements for Effective APN (CD13) Targeting | 1-gen-2016 | Graziadio, A; Zanda, M; Frau, S; Fleming, In; Musolino, M; Dallangelo, S; Baldassarre, M; Piras, M | |
| 4-Cyano-5-(2-thiophenyl)-pyrazoles are high affinity CB1 receptor ligands | 1-gen-2015 | Altomonte, Stefano; Baillie, Gemma L.; Ross, Ruth A.; Zanda, Matteo | |
| An Efficient Route to N-Monosubstituted Guanidino-Lactams | 1-gen-2015 | Tommasi S.; Zanato C.; Carabeo R.; Mangoni A.A.; Dall'Angelo S.; Zanda M. |